Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Mol Genet Metab. 2012 Sep 17;107(3):315–321. doi: 10.1016/j.ymgme.2012.09.016

Table 1.

Subject characteristics prior to the enrollment and during each arm of the study.

Prior to enrollment HDA arm LDA arm
Subject Arginine dose (mg/kg/day) Phenylbutyrate dose (mg/kg/d) Age (yr) Ht (cm) Wt (kg) BMI Average protein intake # Age (yr) Ht (cm) Wt (kg) BMI Average protein intake #
100006 150 None 13.76 169.3 63 21.98 0.67 13.73 169.3 63 21.98 0.70
100551 180 400 4.53 98 18.1 18.85 0.79 4.36 98 17.4 18.12 0.79
101037 400 None 22.33 164.7 61.7 22.75 0.73 22.50 165 60 22.04 0.69
101880 450 None 10.12 130 28.8 17.04 0.83 10.00 130 28 16.57 0.88
102107 125 None 20.29 182 70 21.13 0.63 20.26 183 71 21.20 0.65
102108 150 None 23.33 158 61 24.44 0.60 23.29 157 60 24.34 0.70
102635 350 None 9.06 131 26.9 15.68 0.92 9.10 131 26.9 15.68 0.91
102747 200 None 11.15 127 23.3 14.45 0.83 11.34 127 23.5 14.57 0.89
104591 50 None 13.44 155 38.1 15.86 0.87 13.63 156 41.7 17.14 0.75
105458 60 None 28.61 173 89 29.74 0.59 28.72 173 93 31.07 0.65
106088 135 None 13.83 160 51 19.92 0.78 13.93 160 51 19.92 0.83
#

average intake during the 7 days inpatient stay.